Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157: What the Research Says About Healing and Recovery Yoo Direct Health FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post